Journal:
:hepatitis monthly
0
khashayar hesamizadeh middle east liver disease (meld) center, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran
heidar sharafi middle east liver disease (meld) center, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran
mohammad saeid rezaee-zavareh middle east liver disease (meld) center, tehran, ir iran; students’ research committee, baqiyatallah university of medical sciences, tehran, ir iran
bita behnava middle east liver disease (meld) center, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran
seyed moayed alavian middle east liver disease (meld) center, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran. tel: +98-2188945186, fax: +98-2188945188
evidence acquisition an electronic search of available literature published was conducted in all peer-reviewed journal indexed in pubmed, scopus and google scholar. the literature search was done among articles related treatment of hepatitis c with daas in different patient groups with mass screening of the patients and cost benefit of new treatments as main key words. results there are major s...
